2015 Annual Meeting | Controversies in Neurology Plenary Session
| 05:30 PM - 06:00 PM |
Should Whole Exome Sequencing be Part of Neurologic Care Today?
Christine Klein, MD, Claes Wahlestedt, MD, PhD |
|
| 06:00 PM - 06:30 PM |
Is the Science of Stem Cells Ready for Clinical Trials in Neurologic Disease?
C. W. Olanow, MD, Clive Svendsen, PhD |
|
| 06:30 PM - 07:00 PM |
Should Neurologists Prescribe Opioids for Chronic Pain?
Charles E. Argoff, MD, Gary M. Franklin, MD, MPH, FAAN |
| Charles E. Argoff, MD | Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nevro. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for XGene. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Colllegium. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Argoff has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Scilex. The institution of Dr. Argoff has received research support from Lilly. The institution of Dr. Argoff has received research support from Lundbeck. The institution of Dr. Argoff has received research support from Abbvie. The institution of Dr. Argoff has received research support from Vertex. Dr. Argoff has received publishing royalties from a publication relating to health care. |
| Gary M. Franklin, MD, MPH, FAAN | The institution of Dr. Franklin has received research support from PCORI. |
| Christine Klein, MD | Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Centogene and Retromer Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Mov Disord, Ann Neurol, Science Adv. The institution of Dr. Klein has received research support from Centogene. Dr. Klein has received publishing royalties from a publication relating to health care. |
| Claes Wahlestedt, MD, PhD | No disclosure on file |
| Clive Svendsen, PhD | No disclosure on file |
| C. W. Olanow, MD | Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation. |